Trauma & Control: Self-Regulation of Brain Networks in PTSD - TraumaCtrl

Radboud Universitair Medisch Centrum0 个研究点目标入组 32 人开始时间: 待定最近更新: 2024年4月15日

试验速览

暂无简介。

•PTSD symptoms, according to DSM-5 criteria, as noted by participant's clinician

•History of episode of psychotic or manic symptoms.
•Daily intake of benzodiazepines, or otherwise irregular intake of
•benzodiazepines (*when needed*) but unable to withhold intake from the day
•prior to each test session until the end of the each test session. An exception
•is made for low doses of short-acting benzodiazepines that are prescribed for
•insomnia (i.e. as sleep medication).
•A relevant neurological disorder (e.g., stroke, epilepsy, Multiple Sclerosis)
•or severe physical disorder which is likely to impact assessment procedures or
•Reports to be unable or unwilling to withhold recreational drug use and limit
•alcohol use to maximally two units per day from the day prior to each test
•session until the end of the each test session.
•Reports to be unable or unwilling to discuss frequency and timing of smoking
•during and around study procedures, and adhere to an agreed smoking schedule
•(personally adjusted to balance feasibility, participant needs and reliability
•of study outcomes).
•General learning disability, or known to have intelligence Quotient (IQ) < 70
•Body weight >250 Kg.
•For women: pregnancy
•Contraindications for MRI scanning (e.g., pacemaker, implanted metal parts,
•metal in or around the body, deep brain stimulation, severe claustrophobia).

发起方